SYRE

#1066
Spyre Therapeutics, Inc. - Common Stock
80.4 5 USD
-0.06%
Preço de mercado
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
80.45
85.32
Faixa anual
21.15
110.18
Mudança diária
-6.34%
Mudança mensal
-11.42%
Mudança em 6 meses
+18.75%
Mudança anual
+236.47%
Fechamento anterior
85.9 0
Abertura
85.1 3
Mínimo
80.4 5
Máximo
85.3 2
Abrir gráfico completo

Indicadores financeiros

Visão geral Relatórios Estatísticas Documentos

2021

Current report, 05 Aug 2021

Spyre Therapeutics, Inc. current report, 05 August 2021
8-K

Current report, 08 Jul 2021

Spyre Therapeutics, Inc. current report, 08 July 2021
8-K

Quarterly report, Q2 FY2021

Spyre Therapeutics, Inc. quarterly report, Q2 FY2021
10-Q

Current report, 24 Jun 2021

Spyre Therapeutics, Inc. current report, 24 June 2021
8-K

Current report, 18 Jun 2021

Spyre Therapeutics, Inc. current report, 18 June 2021
8-K

Current report, 08 Jun 2021

Spyre Therapeutics, Inc. current report, 08 June 2021
8-K

Current report, 10 May 2021

Spyre Therapeutics, Inc. current report, 10 May 2021
8-K

Quarterly report, Q1 FY2021

Spyre Therapeutics, Inc. quarterly report, Q1 FY2021
10-Q

Current report, 21 Mar 2021

Spyre Therapeutics, Inc. current report, 21 March 2021
8-K

Current report, 18 Mar 2021

Spyre Therapeutics, Inc. current report, 18 March 2021
8-K

Notícias